TransCode Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.84	17.81	5.81	2.77	4.97	20.83
Cash & Short-Term Investments	12.84	17.81	5.81	2.77	4.97	20.83
Cash Growth	10.95%	206.54%	109.97%	-44.30%	-76.14%	2415.16%
Other Receivables	0	0.95	-	-	0.36	-
Total Trade Receivables	0	0.95	-	-	0.36	-
Other Current Assets	3.91	3.22	1.28	1.69	2.05	1.91
Total Current Assets	16.75	21.98	7.09	4.46	7.38	22.73
Net Property, Plant & Equipment	0.35	0.37	0.09	0.6	0.21	0.21
Other Intangible Assets	114.3	114.3	-	-	-	-
Goodwill	25.74	25.74	-	-	-	-
Other Long-Term Assets	0.03	-	0.11	0.11	-	-
Total Assets	157.17	162.4	7.29	5.17	7.59	22.94
Accounts Payable	5.29	3.49	2.71	3.05	4.35	2.5
Current Portion of Leases	-	-	0.04	0.41	-	-
Unearned Revenue	0.09	-	0.03	0.03	-	0.03
Total Current Liabilities	5.38	3.49	2.77	3.49	4.35	2.53
Long-Term Leases	-	-	-	0.04	-	-
Other Long-Term Liabilities	7.27	7.02	6.54	-	-	-
Total Long-Term Liabilities	7.27	7.02	6.54	0.04	-	-
Total Liabilities	12.64	10.52	9.31	3.53	4.35	2.53
Preferred Stock	0	-	-	-	-	-
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	116.9	108.2	61.18	48.06	31.11	30.71
Retained Earnings	-115.65	-97.86	-63.2	-46.42	-27.87	-10.31
Total Common Shareholders' Equity	1.25	10.34	-2.02	1.64	3.24	20.4
Minority Interest	143.27	141.55	-	-	-	-
Shareholders' Equity	144.52	151.88	-2.02	1.64	3.24	20.4
Total Liabilities & Equity	157.17	162.4	7.29	5.17	7.59	22.94
Total Debt	-	0	0.04	0.45	0	0
Net Cash (Debt)	12.84	17.81	5.77	2.32	4.97	20.83
Net Cash Growth	-27.94%	208.58%	149.14%	-53.36%	-76.14%	-
Net Cash Per Share	14.68	25.83	459.69	11961.09	282999.27	1186235.14
Book Value	1.25	10.34	-2.02	1.64	3.24	20.4
Book Value Per Share	1.43	14.99	-160.75	8470.28	184589.00	1162220.00
Tangible Book Value	-138.79	-129.71	-2.02	1.64	3.24	20.4
Tangible Book Value Per Share	-158.74	-188.06	-160.75	8470.28	184589.00	1162220.00

SEC Filings: 10-K · 10-Q